Carboplatin & Paclitaxel Alone or in Combo w/Bevacizumab (ovarian cancer)

ID Number 05-0982-00213

Principal Investigator(s)
Jamal Rahaman

Department(s) or Division(s)
Obstetrics, Gynecology, and Reproductive Science


One purpose of this study is to compare the combination of carboplatin, paclitaxel and bevacizumab to the standard combination of carboplatin and paclitaxel alone. A second purpose of this study is to determine if a second surgery to remove tumor followed by chemotherapy can increase the time that patients remain disease free.

Contact Information
Jamal Rahaman MD

Recruiting Patients: No